Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 15 Lung Neoplasms 11 Colonic Neoplasms 10 Breast Neoplasms 9 Brain Neoplasms 7 Prostatic Neoplasms 4 Emergence Delirium 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 3 Respiratory Aspiration 3 Rectal Neoplasms 3 Pituitary Neoplasms 3 Neoplastic Cells, Circulating 3 Hypoxia 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Agnosia 3 Supratentorial Neoplasms 2 Postoperative Complications 2 Patient Satisfaction 2 Pain, Postoperative 2 Pain 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Liver Neoplasms 2 Leukemia 2 Delirium 2 Colorectal Neoplasms 2 Abdominal Neoplasms 2

Interventions

Fulvestrant 3 palbociclib 2 Letrozole 2 Anastrozole 2 venetoclax 1 pyrotinib 1 pertuzumab 1 penpulimab 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Induction Chemotherapy 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasm Female × Propofol × Clear all

NCT03117894 2021-06-04

PECS-2 for Breast Surgery

Umeå University

Phase NA Completed

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡